As of December 31, 2025, Nutritional Growth Solutions Ltd. carries a market capitalization of 7.35M, placing it among publicly traded companies globally. Its enterprise value stands at 6.77M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 7.35M |
| Enterprise Value | 6.77M |
As of December 31, 2025, Nutritional Growth Solutions Ltd. has 333.09M shares outstanding.
| Shares Outstanding | 333.09M |
These figures are as of December 31, 2025. The price-to-sales ratio is 1.55, and the price-to-book ratio stands at 16.98.
| PS Ratio | 1.55 |
| PB Ratio | 16.98 |
| P/TBV Ratio | 16.98 |
These figures are as of December 31, 2025. The EV/Sales ratio of 2.78 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 6.77M versus a market cap of 7.35M, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 2.78 |
As of December 31, 2025, Nutritional Growth Solutions Ltd. maintains a current ratio of 1.19, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 43.94, indicating elevated leverage, while an interest coverage ratio of -5.10 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.19 |
| Quick Ratio | 0.98 |
| Debt / Equity | 43.94 |
| Debt / EBITDA | -0.08 |
| Interest Coverage | -5.10 |
These figures cover the twelve months ended December 31, 2025. Return on assets (ROA) is negative at -135.82, reflecting losses generated across the asset base. Inventory turnover of 3.19 indicates how many times Nutritional Growth Solutions Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Assets (ROA) | -135.82 |
| Inventory Turnover | 3.19 |
As of the close on October 22, 2026, Nutritional Growth Solutions Ltd.'s stock has declined approximately 15.00% over the past 52 weeks. The 50-day moving average sits at 0.02, while the 200-day moving average is 0.02.
| 52-Week Price Change | -15.00% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.02 |
Over the twelve months ended December 31, 2025, Nutritional Growth Solutions Ltd. generated 2.44M in revenue and converted that into -2.54M in net income, yielding earnings per share of -0.01. EBITDA reached -2.36M, while operating income came in at -2.38M.
| Revenue | 2.44M |
| Gross Profit | 380,517.40 |
| Operating Income | -2.38M |
| Pretax Income | -2.54M |
| Net Income | -2.54M |
| EBITDA | -2.36M |
| EBIT | -2.38M |
| Earnings Per Share (EPS) | -0.01 |
As of December 31, 2025, Nutritional Growth Solutions Ltd. holds 774,517.70 in cash and equivalents against 190,258.70 in total debt, resulting in a net debt position of -584,259.00. Total book value stands at 432,950.90, with working capital of 432,950.90 providing operational flexibility.
| Cash & Cash Equivalents | 774,517.70 |
| Total Debt | 190,258.70 |
| Net Debt | -584,259.00 |
| Equity (Book Value) | 432,950.90 |
| Working Capital | 432,950.90 |
Over the twelve months ended December 31, 2025, Nutritional Growth Solutions Ltd. posted a gross margin of 15.61, reflecting its pricing power and cost economics. The operating margin of -97.85 and net profit margin of -104.06 provide insight into operational efficiency.
| Gross Margin | 15.61 |
| Operating Margin | -97.85 |
| Pretax Margin | -104.06 |
| Profit Margin | -104.06 |
| EBITDA Margin | -96.87 |
These figures cover the twelve months ended December 31, 2025. Total shareholder yield is negative at -30.98, meaning Nutritional Growth Solutions Ltd. raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -30.98 |
Nutritional Growth Solutions Ltd.'s most recent stock split took place on August 5, 2024 with a 10:1 split ratio.
| Last Split Date | 8/5/2024 |
| Split Ratio | 10:1 |
As of December 31, 2025, Nutritional Growth Solutions Ltd. has an Altman Z-Score of -16.12, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -16.12 |
Already premium?